Selected research
Industry Research
Nifedipine Injection Industry Research Report 2026
Market perspective
The global Nifedipine Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Nifedipine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Nifedipine Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Nifedipine Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Nifedipine Injection include Teva, Medcalo, Mylan, Pfizer, Cisen Pharmaceutical, Wuhan Binhu Shuanghe Pharmaceutical, Bayer, Pharmaoffer and AdvaCare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Nifedipine Injection market in terms of revenue (US$ million) and, where applicable, sales volume (L), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/L) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nifedipine Injection Market by Company
Teva
Medcalo
Mylan
Pfizer
Cisen Pharmaceutical
Wuhan Binhu Shuanghe Pharmaceutical
Bayer
Pharmaoffer
AdvaCare
Nifedipine Injection Segment by Type
10mg/2ml
20mg/2ml
Nifedipine Injection Segment by Application
Hypertension
Angina (Chest Pain)
Nifedipine Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Nifedipine Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Nifedipine Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Nifedipine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg/2ml
- 20mg/2ml
Applications
- Hypertension
- Angina (Chest Pain)
Companies covered
- Teva
- Medcalo
- Mylan
- Pfizer
- Cisen Pharmaceutical
- Wuhan Binhu Shuanghe Pharmaceutical
- Bayer
- Pharmaoffer
- AdvaCare
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Nifedipine Injection Market Size (2021-2032)
- 2.2.2 Global Nifedipine Injection Sales (2021-2032)
- 2.2.3 Global Nifedipine Injection Market Average Price (2021-2032)
- 2.3 Nifedipine Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 10mg/2ml
- 2.3.3 20mg/2ml
- 2.4 Nifedipine Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hypertension
- 2.4.3 Angina (Chest Pain)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Nifedipine Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Nifedipine Injection Sales (L) of Manufacturers (2021-2026)
- 3.3 Global Nifedipine Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Nifedipine Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Nifedipine Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Nifedipine Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Nifedipine Injection, Product Type & Application
- 3.8 Global Manufacturers of Nifedipine Injection, Established Date
- 3.9 Global Nifedipine Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Nifedipine Injection Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Medcalo
- 4.2.1 Medcalo Company Information
- 4.2.2 Medcalo Business Overview
- 4.2.3 Medcalo Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Medcalo Nifedipine Injection Product Portfolio
- 4.2.5 Medcalo Recent Developments
- 4.3 Mylan
- 4.3.1 Mylan Company Information
- 4.3.2 Mylan Business Overview
- 4.3.3 Mylan Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Mylan Nifedipine Injection Product Portfolio
- 4.3.5 Mylan Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Nifedipine Injection Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Cisen Pharmaceutical
- 4.5.1 Cisen Pharmaceutical Company Information
- 4.5.2 Cisen Pharmaceutical Business Overview
- 4.5.3 Cisen Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cisen Pharmaceutical Nifedipine Injection Product Portfolio
- 4.5.5 Cisen Pharmaceutical Recent Developments
- 4.6 Wuhan Binhu Shuanghe Pharmaceutical
- 4.6.1 Wuhan Binhu Shuanghe Pharmaceutical Company Information
- 4.6.2 Wuhan Binhu Shuanghe Pharmaceutical Business Overview
- 4.6.3 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Wuhan Binhu Shuanghe Pharmaceutical Nifedipine Injection Product Portfolio
- 4.6.5 Wuhan Binhu Shuanghe Pharmaceutical Recent Developments
- 4.7 Bayer
- 4.7.1 Bayer Company Information
- 4.7.2 Bayer Business Overview
- 4.7.3 Bayer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bayer Nifedipine Injection Product Portfolio
- 4.7.5 Bayer Recent Developments
- 4.8 Pharmaoffer
- 4.8.1 Pharmaoffer Company Information
- 4.8.2 Pharmaoffer Business Overview
- 4.8.3 Pharmaoffer Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pharmaoffer Nifedipine Injection Product Portfolio
- 4.8.5 Pharmaoffer Recent Developments
- 4.9 AdvaCare
- 4.9.1 AdvaCare Company Information
- 4.9.2 AdvaCare Business Overview
- 4.9.3 AdvaCare Nifedipine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 AdvaCare Nifedipine Injection Product Portfolio
- 4.9.5 AdvaCare Recent Developments
5 Global Nifedipine Injection Market Scenario by Region
- 5.1 Global Nifedipine Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Nifedipine Injection Sales by Region: 2021-2032
- 5.2.1 Global Nifedipine Injection Sales by Region: 2021-2026
- 5.2.2 Global Nifedipine Injection Sales by Region: 2027-2032
- 5.3 Global Nifedipine Injection Revenue by Region: 2021-2032
- 5.3.1 Global Nifedipine Injection Revenue by Region: 2021-2026
- 5.3.2 Global Nifedipine Injection Revenue by Region: 2027-2032
- 5.4 North America Nifedipine Injection Market Facts & Figures by Country
- 5.4.1 North America Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Nifedipine Injection Sales by Country (2021-2032)
- 5.4.3 North America Nifedipine Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Nifedipine Injection Market Facts & Figures by Country
- 5.5.1 Europe Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Nifedipine Injection Sales by Country (2021-2032)
- 5.5.3 Europe Nifedipine Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Nifedipine Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Nifedipine Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Nifedipine Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Nifedipine Injection Market Facts & Figures by Country
- 5.7.1 South America Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Nifedipine Injection Sales by Country (2021-2032)
- 5.7.3 South America Nifedipine Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Nifedipine Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Nifedipine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Nifedipine Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Nifedipine Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Nifedipine Injection Sales by Type (2021-2032)
- 6.1.1 Global Nifedipine Injection Sales by Type (2021-2032) & (L)
- 6.1.2 Global Nifedipine Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Nifedipine Injection Revenue by Type (2021-2032)
- 6.2.1 Global Nifedipine Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Nifedipine Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Nifedipine Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Nifedipine Injection Sales by Application (2021-2032)
- 7.1.1 Global Nifedipine Injection Sales by Application (2021-2032) & (L)
- 7.1.2 Global Nifedipine Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Nifedipine Injection Revenue by Application (2021-2032)
- 7.2.1 Global Nifedipine Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Nifedipine Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Nifedipine Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Nifedipine Injection Value Chain Analysis
- 8.1.1 Nifedipine Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Nifedipine Injection Production Mode & Process
- 8.2 Nifedipine Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Nifedipine Injection Distributors
- 8.2.3 Nifedipine Injection Customers
9 Global Nifedipine Injection Analyzing Market Dynamics
- 9.1 Nifedipine Injection Industry Trends
- 9.2 Nifedipine Injection Industry Drivers
- 9.3 Nifedipine Injection Industry Opportunities and Challenges
- 9.4 Nifedipine Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst